Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
27 July 2010Website:
http://www.xwell.comNext earnings report:
16 April 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 20 Nov 2024 22:15:28 GMTDividend
Analysts recommendations
Institutional Ownership
XWEL Latest News
XWELL, Inc. (NASDAQ:XWEL ) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants Suzanne Scrabis – Chief Financial Officer Ezra Ernst – Chief Executive Officer Conference Call Participants Operator Good day, and welcome to the XWELL, Inc. Third Quarter 2024 Results Conference Call. All participants will be in a listen-only mode.
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the third quarter and nine-month period ended September 30, 2024.
Strategic leadership change will drive further growth and expansion among core business units Strategic leadership change will drive further growth and expansion among core business units
Partnership will bring growth opportunities and expands XpresSpa's brand to more travelers Partnership will bring growth opportunities and expands XpresSpa's brand to more travelers
NEW YORK, Aug. 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (the “Company”) announced today that its Board of Directors has adopted a Tax Benefits Preservation Plan (the “Plan”) intended to preserve the value of certain of the Company's tax attributes related to previously recorded net operating losses (the “Tax Attributes”).
NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the second quarter ended June 30, 2024.
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today issued the following statement in response to CPC Pain & Wellness SPV, LLC's (“CPC”) decision to withdraw its threatened proxy fight and related lawsuit against XWELL, in connection with the Company's 2024 annual meeting of stockholders (the “2024 Annual Meeting”).
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced the closing of its previously announced registered direct offering priced at a premium to market for the issuance and sale of an aggregate of 652,705 shares of its common stock, par value $0.01 per share, at a purchase price of $2.18 per share.
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Today, CPC Pain & Wellness SPV, LLC (“CPC”), a significant XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”) shareholder that beneficially owns 394,200 or 9.42% of XWELL's outstanding shares, issued the below letter to its fellow shareholders. The letter informs shareholders of CPC's recent lawsuit filing against the incumbent members of XWELL's Board of Directors for breach of their fiduciary duties and for the Board's wrongful and inequitable efforts to prevent CPC from nominating a competing slate of directors and consequently denying shareholders the opportunity to choose who they elect to XWELL's Board at the upcoming annual shareholder meeting. In its letter, CPC details how current Board members have personally benefited from XWELL while overseeing an astounding decline in XWELL shareholder value and substantial net losses. CPC also shares in the below letter its vision for restoring and maximizing shareholder value.
NEW YORK--(BUSINESS WIRE)--XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced that the notice materials submitted by CPC Pain & Wellness SPV, LLC (“CPC”), which purported to provide notice of CPC's intent to nominate four candidates for election to the Company's five-member Board of Directors (the “Board”) at the 2024 Annual Meeting of Stockholders, is invalid. CPC, a special purpose vehicle that was recently forme.
What type of business is XWELL?
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
What sector is XWELL in?
XWELL is in the Healthcare sector
What industry is XWELL in?
XWELL is in the Diagnostics & Research industry
What country is XWELL from?
XWELL is headquartered in United States
When did XWELL go public?
XWELL initial public offering (IPO) was on 27 July 2010
What is XWELL website?
https://www.xwell.com
Is XWELL in the S&P 500?
No, XWELL is not included in the S&P 500 index
Is XWELL in the NASDAQ 100?
No, XWELL is not included in the NASDAQ 100 index
Is XWELL in the Dow Jones?
No, XWELL is not included in the Dow Jones index
When was XWELL the previous earnings report?
No data
When does XWELL earnings report?
The next expected earnings date for XWELL is 16 April 2025